img

Global AI Drug Development Platform Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global AI Drug Development Platform Market Insights, Forecast to 2034

Market Analysis and InsightsGlobal AI Drug Development Platform Market
Global AI Drug Development Platform market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, AI Drug Development Platform industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
Globally, AI Drug Development Platform key companies include Insilico Medicine, MindRank, BenevolentAI, Exscientia, Deep Pharma Intelligence, Delta4, DNDi, Standigm and Genesis Therapeutics, etc. Insilico Medicine, MindRank, BenevolentAI are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of AI Drug Development Platform were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the share will be % in 2033. Moreover, China, plays a key role in the whole AI Drug Development Platform market and estimated to attract more attentions from industry insiders and investors.
AI Drug Development Platform can be divided into Software Provider Mode, CRO Service Mode and Self-Development Pipeline Mode,, etc. Software Provider Mode is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2033.
AI Drug Development Platform is widely used in various fields, such as SMEs and Large Enterprises, etc. SMEs provides greatest supports to the AI Drug Development Platform industry development. In 2022, global % revenue of AI Drug Development Platform went into SMEs filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global AI Drug Development Platform market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global AI Drug Development Platform market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Insilico Medicine
MindRank
BenevolentAI
Exscientia
Deep Pharma Intelligence
Delta4
DNDi
Standigm
Genesis Therapeutics
Data2Discovery
Unlearn.AI
Deep Intelligent Pharma
CarbonSilicon AI Technology
XtalPi
Tencent
Fastone
Stonewise
HitGen
Galixir
Matwings Technology
Alibaba
Segment by Type
Software Provider Mode
CRO Service Mode
Self-Development Pipeline Mode

Segment by Application


SMEs
Large Enterprises
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, AI Drug Development Platform introduction, etc. AI Drug Development Platform Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of AI Drug Development Platform
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global AI Drug Development Platform Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Software Provider Mode
1.2.3 CRO Service Mode
1.2.4 Self-Development Pipeline Mode
1.3 Market by Application
1.3.1 Global AI Drug Development Platform Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 SMEs
1.3.3 Large Enterprises
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global AI Drug Development Platform Market Perspective (2018-2033)
2.2 Global AI Drug Development Platform Growth Trends by Region
2.2.1 AI Drug Development Platform Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 AI Drug Development Platform Historic Market Size by Region (2018-2023)
2.2.3 AI Drug Development Platform Forecasted Market Size by Region (2024-2033)
2.3 AI Drug Development Platform Market Dynamics
2.3.1 AI Drug Development Platform Industry Trends
2.3.2 AI Drug Development Platform Market Drivers
2.3.3 AI Drug Development Platform Market Challenges
2.3.4 AI Drug Development Platform Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue AI Drug Development Platform by Players
3.1.1 Global AI Drug Development Platform Revenue by Players (2018-2023)
3.1.2 Global AI Drug Development Platform Revenue Market Share by Players (2018-2023)
3.2 Global AI Drug Development Platform Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of AI Drug Development Platform, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global AI Drug Development Platform Market Concentration Ratio
3.4.1 Global AI Drug Development Platform Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by AI Drug Development Platform Revenue in 2022
3.5 Global Key Players of AI Drug Development Platform Head office and Area Served
3.6 Global Key Players of AI Drug Development Platform, Product and Application
3.7 Global Key Players of AI Drug Development Platform, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 AI Drug Development Platform Breakdown Data by Type
4.1 Global AI Drug Development Platform Historic Market Size by Type (2018-2023)
4.2 Global AI Drug Development Platform Forecasted Market Size by Type (2024-2033)
5 AI Drug Development Platform Breakdown Data by Application
5.1 Global AI Drug Development Platform Historic Market Size by Application (2018-2023)
5.2 Global AI Drug Development Platform Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America AI Drug Development Platform Market Size (2018-2033)
6.2 North America AI Drug Development Platform Market Size by Type
6.2.1 North America AI Drug Development Platform Market Size by Type (2018-2023)
6.2.2 North America AI Drug Development Platform Market Size by Type (2024-2033)
6.2.3 North America AI Drug Development Platform Market Share by Type (2018-2033)
6.3 North America AI Drug Development Platform Market Size by Application
6.3.1 North America AI Drug Development Platform Market Size by Application (2018-2023)
6.3.2 North America AI Drug Development Platform Market Size by Application (2024-2033)
6.3.3 North America AI Drug Development Platform Market Share by Application (2018-2033)
6.4 North America AI Drug Development Platform Market Size by Country
6.4.1 North America AI Drug Development Platform Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America AI Drug Development Platform Market Size by Country (2018-2023)
6.4.3 North America AI Drug Development Platform Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe AI Drug Development Platform Market Size (2018-2033)
7.2 Europe AI Drug Development Platform Market Size by Type
7.2.1 Europe AI Drug Development Platform Market Size by Type (2018-2023)
7.2.2 Europe AI Drug Development Platform Market Size by Type (2024-2033)
7.2.3 Europe AI Drug Development Platform Market Share by Type (2018-2033)
7.3 Europe AI Drug Development Platform Market Size by Application
7.3.1 Europe AI Drug Development Platform Market Size by Application (2018-2023)
7.3.2 Europe AI Drug Development Platform Market Size by Application (2024-2033)
7.3.3 Europe AI Drug Development Platform Market Share by Application (2018-2033)
7.4 Europe AI Drug Development Platform Market Size by Country
7.4.1 Europe AI Drug Development Platform Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe AI Drug Development Platform Market Size by Country (2018-2023)
7.4.3 Europe AI Drug Development Platform Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China AI Drug Development Platform Market Size (2018-2033)
8.2 China AI Drug Development Platform Market Size by Type
8.2.1 China AI Drug Development Platform Market Size by Type (2018-2023)
8.2.2 China AI Drug Development Platform Market Size by Type (2024-2033)
8.2.3 China AI Drug Development Platform Market Share by Type (2018-2033)
8.3 China AI Drug Development Platform Market Size by Application
8.3.1 China AI Drug Development Platform Market Size by Application (2018-2023)
8.3.2 China AI Drug Development Platform Market Size by Application (2024-2033)
8.3.3 China AI Drug Development Platform Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia AI Drug Development Platform Market Size (2018-2033)
9.2 Asia AI Drug Development Platform Market Size by Type
9.2.1 Asia AI Drug Development Platform Market Size by Type (2018-2023)
9.2.2 Asia AI Drug Development Platform Market Size by Type (2024-2033)
9.2.3 Asia AI Drug Development Platform Market Share by Type (2018-2033)
9.3 Asia AI Drug Development Platform Market Size by Application
9.3.1 Asia AI Drug Development Platform Market Size by Application (2018-2023)
9.3.2 Asia AI Drug Development Platform Market Size by Application (2024-2033)
9.3.3 Asia AI Drug Development Platform Market Share by Application (2018-2033)
9.4 Asia AI Drug Development Platform Market Size by Region
9.4.1 Asia AI Drug Development Platform Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia AI Drug Development Platform Market Size by Region (2018-2023)
9.4.3 Asia AI Drug Development Platform Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America AI Drug Development Platform Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America AI Drug Development Platform Market Size by Type
10.2.1 Middle East, Africa, and Latin America AI Drug Development Platform Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America AI Drug Development Platform Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America AI Drug Development Platform Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America AI Drug Development Platform Market Size by Application
10.3.1 Middle East, Africa, and Latin America AI Drug Development Platform Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America AI Drug Development Platform Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America AI Drug Development Platform Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America AI Drug Development Platform Market Size by Country
10.4.1 Middle East, Africa, and Latin America AI Drug Development Platform Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America AI Drug Development Platform Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America AI Drug Development Platform Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Insilico Medicine
11.1.1 Insilico Medicine Company Details
11.1.2 Insilico Medicine Business Overview
11.1.3 Insilico Medicine AI Drug Development Platform Introduction
11.1.4 Insilico Medicine Revenue in AI Drug Development Platform Business (2018-2023)
11.1.5 Insilico Medicine Recent Developments
11.2 MindRank
11.2.1 MindRank Company Details
11.2.2 MindRank Business Overview
11.2.3 MindRank AI Drug Development Platform Introduction
11.2.4 MindRank Revenue in AI Drug Development Platform Business (2018-2023)
11.2.5 MindRank Recent Developments
11.3 BenevolentAI
11.3.1 BenevolentAI Company Details
11.3.2 BenevolentAI Business Overview
11.3.3 BenevolentAI AI Drug Development Platform Introduction
11.3.4 BenevolentAI Revenue in AI Drug Development Platform Business (2018-2023)
11.3.5 BenevolentAI Recent Developments
11.4 Exscientia
11.4.1 Exscientia Company Details
11.4.2 Exscientia Business Overview
11.4.3 Exscientia AI Drug Development Platform Introduction
11.4.4 Exscientia Revenue in AI Drug Development Platform Business (2018-2023)
11.4.5 Exscientia Recent Developments
11.5 Deep Pharma Intelligence
11.5.1 Deep Pharma Intelligence Company Details
11.5.2 Deep Pharma Intelligence Business Overview
11.5.3 Deep Pharma Intelligence AI Drug Development Platform Introduction
11.5.4 Deep Pharma Intelligence Revenue in AI Drug Development Platform Business (2018-2023)
11.5.5 Deep Pharma Intelligence Recent Developments
11.6 Delta4
11.6.1 Delta4 Company Details
11.6.2 Delta4 Business Overview
11.6.3 Delta4 AI Drug Development Platform Introduction
11.6.4 Delta4 Revenue in AI Drug Development Platform Business (2018-2023)
11.6.5 Delta4 Recent Developments
11.7 DNDi
11.7.1 DNDi Company Details
11.7.2 DNDi Business Overview
11.7.3 DNDi AI Drug Development Platform Introduction
11.7.4 DNDi Revenue in AI Drug Development Platform Business (2018-2023)
11.7.5 DNDi Recent Developments
11.8 Standigm
11.8.1 Standigm Company Details
11.8.2 Standigm Business Overview
11.8.3 Standigm AI Drug Development Platform Introduction
11.8.4 Standigm Revenue in AI Drug Development Platform Business (2018-2023)
11.8.5 Standigm Recent Developments
11.9 Genesis Therapeutics
11.9.1 Genesis Therapeutics Company Details
11.9.2 Genesis Therapeutics Business Overview
11.9.3 Genesis Therapeutics AI Drug Development Platform Introduction
11.9.4 Genesis Therapeutics Revenue in AI Drug Development Platform Business (2018-2023)
11.9.5 Genesis Therapeutics Recent Developments
11.10 Data2Discovery
11.10.1 Data2Discovery Company Details
11.10.2 Data2Discovery Business Overview
11.10.3 Data2Discovery AI Drug Development Platform Introduction
11.10.4 Data2Discovery Revenue in AI Drug Development Platform Business (2018-2023)
11.10.5 Data2Discovery Recent Developments
11.11 Unlearn.AI
11.11.1 Unlearn.AI Company Details
11.11.2 Unlearn.AI Business Overview
11.11.3 Unlearn.AI AI Drug Development Platform Introduction
11.11.4 Unlearn.AI Revenue in AI Drug Development Platform Business (2018-2023)
11.11.5 Unlearn.AI Recent Developments
11.12 Deep Intelligent Pharma
11.12.1 Deep Intelligent Pharma Company Details
11.12.2 Deep Intelligent Pharma Business Overview
11.12.3 Deep Intelligent Pharma AI Drug Development Platform Introduction
11.12.4 Deep Intelligent Pharma Revenue in AI Drug Development Platform Business (2018-2023)
11.12.5 Deep Intelligent Pharma Recent Developments
11.13 CarbonSilicon AI Technology
11.13.1 CarbonSilicon AI Technology Company Details
11.13.2 CarbonSilicon AI Technology Business Overview
11.13.3 CarbonSilicon AI Technology AI Drug Development Platform Introduction
11.13.4 CarbonSilicon AI Technology Revenue in AI Drug Development Platform Business (2018-2023)
11.13.5 CarbonSilicon AI Technology Recent Developments
11.14 XtalPi
11.14.1 XtalPi Company Details
11.14.2 XtalPi Business Overview
11.14.3 XtalPi AI Drug Development Platform Introduction
11.14.4 XtalPi Revenue in AI Drug Development Platform Business (2018-2023)
11.14.5 XtalPi Recent Developments
11.15 Tencent
11.15.1 Tencent Company Details
11.15.2 Tencent Business Overview
11.15.3 Tencent AI Drug Development Platform Introduction
11.15.4 Tencent Revenue in AI Drug Development Platform Business (2018-2023)
11.15.5 Tencent Recent Developments
11.16 Fastone
11.16.1 Fastone Company Details
11.16.2 Fastone Business Overview
11.16.3 Fastone AI Drug Development Platform Introduction
11.16.4 Fastone Revenue in AI Drug Development Platform Business (2018-2023)
11.16.5 Fastone Recent Developments
11.17 Stonewise
11.17.1 Stonewise Company Details
11.17.2 Stonewise Business Overview
11.17.3 Stonewise AI Drug Development Platform Introduction
11.17.4 Stonewise Revenue in AI Drug Development Platform Business (2018-2023)
11.17.5 Stonewise Recent Developments
11.18 HitGen
11.18.1 HitGen Company Details
11.18.2 HitGen Business Overview
11.18.3 HitGen AI Drug Development Platform Introduction
11.18.4 HitGen Revenue in AI Drug Development Platform Business (2018-2023)
11.18.5 HitGen Recent Developments
11.19 Galixir
11.19.1 Galixir Company Details
11.19.2 Galixir Business Overview
11.19.3 Galixir AI Drug Development Platform Introduction
11.19.4 Galixir Revenue in AI Drug Development Platform Business (2018-2023)
11.19.5 Galixir Recent Developments
11.20 Matwings Technology
11.20.1 Matwings Technology Company Details
11.20.2 Matwings Technology Business Overview
11.20.3 Matwings Technology AI Drug Development Platform Introduction
11.20.4 Matwings Technology Revenue in AI Drug Development Platform Business (2018-2023)
11.20.5 Matwings Technology Recent Developments
11.21 Alibaba
11.21.1 Alibaba Company Details
11.21.2 Alibaba Business Overview
11.21.3 Alibaba AI Drug Development Platform Introduction
11.21.4 Alibaba Revenue in AI Drug Development Platform Business (2018-2023)
11.21.5 Alibaba Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global AI Drug Development Platform Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Software Provider Mode
Table 3. Key Players of CRO Service Mode
Table 4. Key Players of Self-Development Pipeline Mode
Table 5. Global AI Drug Development Platform Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 6. Global AI Drug Development Platform Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global AI Drug Development Platform Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global AI Drug Development Platform Market Share by Region (2018-2023)
Table 9. Global AI Drug Development Platform Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global AI Drug Development Platform Market Share by Region (2024-2033)
Table 11. AI Drug Development Platform Market Trends
Table 12. AI Drug Development Platform Market Drivers
Table 13. AI Drug Development Platform Market Challenges
Table 14. AI Drug Development Platform Market Restraints
Table 15. Global AI Drug Development Platform Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global AI Drug Development Platform Revenue Share by Players (2018-2023)
Table 17. Global Top AI Drug Development Platform by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI Drug Development Platform as of 2022)
Table 18. Global AI Drug Development Platform Industry Ranking 2021 VS 2022 VS 2023
Table 19. Global 5 Largest Players Market Share by AI Drug Development Platform Revenue (CR5 and HHI) & (2018-2023)
Table 20. Global Key Players of AI Drug Development Platform, Headquarters and Area Served
Table 21. Global Key Players of AI Drug Development Platform, Product and Application
Table 22. Global Key Players of AI Drug Development Platform, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global AI Drug Development Platform Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global AI Drug Development Platform Revenue Market Share by Type (2018-2023)
Table 26. Global AI Drug Development Platform Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global AI Drug Development Platform Revenue Market Share by Type (2024-2033)
Table 28. Global AI Drug Development Platform Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global AI Drug Development Platform Revenue Share by Application (2018-2023)
Table 30. Global AI Drug Development Platform Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global AI Drug Development Platform Revenue Share by Application (2024-2033)
Table 32. North America AI Drug Development Platform Market Size by Type (2018-2023) & (US$ Million)
Table 33. North America AI Drug Development Platform Market Size by Type (2024-2033) & (US$ Million)
Table 34. North America AI Drug Development Platform Market Size by Application (2018-2023) & (US$ Million)
Table 35. North America AI Drug Development Platform Market Size by Application (2024-2033) & (US$ Million)
Table 36. North America AI Drug Development Platform Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. North America AI Drug Development Platform Market Size by Country (2018-2023) & (US$ Million)
Table 38. North America AI Drug Development Platform Market Size by Country (2024-2033) & (US$ Million)
Table 39. Europe AI Drug Development Platform Market Size by Type (2018-2023) & (US$ Million)
Table 40. Europe AI Drug Development Platform Market Size by Type (2024-2033) & (US$ Million)
Table 41. Europe AI Drug Development Platform Market Size by Application (2018-2023) & (US$ Million)
Table 42. Europe AI Drug Development Platform Market Size by Application (2024-2033) & (US$ Million)
Table 43. Europe AI Drug Development Platform Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Europe AI Drug Development Platform Market Size by Country (2018-2023) & (US$ Million)
Table 45. Europe AI Drug Development Platform Market Size by Country (2024-2033) & (US$ Million)
Table 46. China AI Drug Development Platform Market Size by Type (2018-2023) & (US$ Million)
Table 47. China AI Drug Development Platform Market Size by Type (2024-2033) & (US$ Million)
Table 48. China AI Drug Development Platform Market Size by Application (2018-2023) & (US$ Million)
Table 49. China AI Drug Development Platform Market Size by Application (2024-2033) & (US$ Million)
Table 50. Asia AI Drug Development Platform Market Size by Type (2018-2023) & (US$ Million)
Table 51. Asia AI Drug Development Platform Market Size by Type (2024-2033) & (US$ Million)
Table 52. Asia AI Drug Development Platform Market Size by Application (2018-2023) & (US$ Million)
Table 53. Asia AI Drug Development Platform Market Size by Application (2024-2033) & (US$ Million)
Table 54. Asia AI Drug Development Platform Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 55. Asia AI Drug Development Platform Market Size by Region (2018-2023) & (US$ Million)
Table 56. Asia AI Drug Development Platform Market Size by Region (2024-2033) & (US$ Million)
Table 57. Middle East, Africa, and Latin America AI Drug Development Platform Market Size by Type (2018-2023) & (US$ Million)
Table 58. Middle East, Africa, and Latin America AI Drug Development Platform Market Size by Type (2024-2033) & (US$ Million)
Table 59. Middle East, Africa, and Latin America AI Drug Development Platform Market Size by Application (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America AI Drug Development Platform Market Size by Application (2024-2033) & (US$ Million)
Table 61. Middle East, Africa, and Latin America AI Drug Development Platform Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 62. Middle East, Africa, and Latin America AI Drug Development Platform Market Size by Country (2018-2023) & (US$ Million)
Table 63. Middle East, Africa, and Latin America AI Drug Development Platform Market Size by Country (2024-2033) & (US$ Million)
Table 64. Insilico Medicine Company Details
Table 65. Insilico Medicine Business Overview
Table 66. Insilico Medicine AI Drug Development Platform Product
Table 67. Insilico Medicine Revenue in AI Drug Development Platform Business (2018-2023) & (US$ Million)
Table 68. Insilico Medicine Recent Developments
Table 69. MindRank Company Details
Table 70. MindRank Business Overview
Table 71. MindRank AI Drug Development Platform Product
Table 72. MindRank Revenue in AI Drug Development Platform Business (2018-2023) & (US$ Million)
Table 73. MindRank Recent Developments
Table 74. BenevolentAI Company Details
Table 75. BenevolentAI Business Overview
Table 76. BenevolentAI AI Drug Development Platform Product
Table 77. BenevolentAI Revenue in AI Drug Development Platform Business (2018-2023) & (US$ Million)
Table 78. BenevolentAI Recent Developments
Table 79. Exscientia Company Details
Table 80. Exscientia Business Overview
Table 81. Exscientia AI Drug Development Platform Product
Table 82. Exscientia Revenue in AI Drug Development Platform Business (2018-2023) & (US$ Million)
Table 83. Exscientia Recent Developments
Table 84. Deep Pharma Intelligence Company Details
Table 85. Deep Pharma Intelligence Business Overview
Table 86. Deep Pharma Intelligence AI Drug Development Platform Product
Table 87. Deep Pharma Intelligence Revenue in AI Drug Development Platform Business (2018-2023) & (US$ Million)
Table 88. Deep Pharma Intelligence Recent Developments
Table 89. Delta4 Company Details
Table 90. Delta4 Business Overview
Table 91. Delta4 AI Drug Development Platform Product
Table 92. Delta4 Revenue in AI Drug Development Platform Business (2018-2023) & (US$ Million)
Table 93. Delta4 Recent Developments
Table 94. DNDi Company Details
Table 95. DNDi Business Overview
Table 96. DNDi AI Drug Development Platform Product
Table 97. DNDi Revenue in AI Drug Development Platform Business (2018-2023) & (US$ Million)
Table 98. DNDi Recent Developments
Table 99. Standigm Company Details
Table 100. Standigm Business Overview
Table 101. Standigm AI Drug Development Platform Product
Table 102. Standigm Revenue in AI Drug Development Platform Business (2018-2023) & (US$ Million)
Table 103. Standigm Recent Developments
Table 104. Genesis Therapeutics Company Details
Table 105. Genesis Therapeutics Business Overview
Table 106. Genesis Therapeutics AI Drug Development Platform Product
Table 107. Genesis Therapeutics Revenue in AI Drug Development Platform Business (2018-2023) & (US$ Million)
Table 108. Genesis Therapeutics Recent Developments
Table 109. Data2Discovery Company Details
Table 110. Data2Discovery Business Overview
Table 111. Data2Discovery AI Drug Development Platform Product
Table 112. Data2Discovery Revenue in AI Drug Development Platform Business (2018-2023) & (US$ Million)
Table 113. Data2Discovery Recent Developments
Table 114. Unlearn.AI Company Details
Table 115. Unlearn.AI Business Overview
Table 116. Unlearn.AI AI Drug Development Platform Product
Table 117. Unlearn.AI Revenue in AI Drug Development Platform Business (2018-2023) & (US$ Million)
Table 118. Unlearn.AI Recent Developments
Table 119. Deep Intelligent Pharma Company Details
Table 120. Deep Intelligent Pharma Business Overview
Table 121. Deep Intelligent Pharma AI Drug Development Platform Product
Table 122. Deep Intelligent Pharma Revenue in AI Drug Development Platform Business (2018-2023) & (US$ Million)
Table 123. Deep Intelligent Pharma Recent Developments
Table 124. CarbonSilicon AI Technology Company Details
Table 125. CarbonSilicon AI Technology Business Overview
Table 126. CarbonSilicon AI Technology AI Drug Development Platform Product
Table 127. CarbonSilicon AI Technology Revenue in AI Drug Development Platform Business (2018-2023) & (US$ Million)
Table 128. CarbonSilicon AI Technology Recent Developments
Table 129. XtalPi Company Details
Table 130. XtalPi Business Overview
Table 131. XtalPi AI Drug Development Platform Product
Table 132. XtalPi Revenue in AI Drug Development Platform Business (2018-2023) & (US$ Million)
Table 133. XtalPi Recent Developments
Table 134. Tencent Company Details
Table 135. Tencent Business Overview
Table 136. Tencent AI Drug Development Platform Product
Table 137. Tencent Revenue in AI Drug Development Platform Business (2018-2023) & (US$ Million)
Table 138. Tencent Recent Developments
Table 139. Fastone Company Details
Table 140. Fastone Business Overview
Table 141. Fastone AI Drug Development Platform Product
Table 142. Fastone Revenue in AI Drug Development Platform Business (2018-2023) & (US$ Million)
Table 143. Fastone Recent Developments
Table 144. Stonewise Company Details
Table 145. Stonewise Business Overview
Table 146. Stonewise AI Drug Development Platform Product
Table 147. Stonewise Revenue in AI Drug Development Platform Business (2018-2023) & (US$ Million)
Table 148. Stonewise Recent Developments
Table 149. HitGen Company Details
Table 150. HitGen Business Overview
Table 151. HitGen AI Drug Development Platform Product
Table 152. HitGen Revenue in AI Drug Development Platform Business (2018-2023) & (US$ Million)
Table 153. HitGen Recent Developments
Table 154. Galixir Company Details
Table 155. Galixir Business Overview
Table 156. Galixir AI Drug Development Platform Product
Table 157. Galixir Revenue in AI Drug Development Platform Business (2018-2023) & (US$ Million)
Table 158. Galixir Recent Developments
Table 159. Matwings Technology Company Details
Table 160. Matwings Technology Business Overview
Table 161. Matwings Technology AI Drug Development Platform Product
Table 162. Matwings Technology Revenue in AI Drug Development Platform Business (2018-2023) & (US$ Million)
Table 163. Matwings Technology Recent Developments
Table 164. Alibaba Company Details
Table 165. Alibaba Business Overview
Table 166. Alibaba AI Drug Development Platform Product
Table 167. Alibaba Revenue in AI Drug Development Platform Business (2018-2023) & (US$ Million)
Table 168. Alibaba Recent Developments
Table 169. Research Programs/Design for This Report
Table 170. Key Data Information from Secondary Sources
Table 171. Key Data Information from Primary Sources
List of Figures
Figure 1. Global AI Drug Development Platform Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global AI Drug Development Platform Market Share by Type: 2022 VS 2033
Figure 3. Software Provider Mode Features
Figure 4. CRO Service Mode Features
Figure 5. Self-Development Pipeline Mode Features
Figure 6. Global AI Drug Development Platform Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 7. Global AI Drug Development Platform Market Share by Application: 2022 VS 2033
Figure 8. SMEs Case Studies
Figure 9. Large Enterprises Case Studies
Figure 10. AI Drug Development Platform Report Years Considered
Figure 11. Global AI Drug Development Platform Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global AI Drug Development Platform Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global AI Drug Development Platform Market Share by Region: 2022 VS 2033
Figure 14. Global AI Drug Development Platform Market Share by Players in 2022
Figure 15. Global Top AI Drug Development Platform Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI Drug Development Platform as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by AI Drug Development Platform Revenue in 2022
Figure 17. North America AI Drug Development Platform Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America AI Drug Development Platform Market Share by Type (2018-2033)
Figure 19. North America AI Drug Development Platform Market Share by Application (2018-2033)
Figure 20. North America AI Drug Development Platform Market Share by Country (2018-2033)
Figure 21. United States AI Drug Development Platform Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada AI Drug Development Platform Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe AI Drug Development Platform Market Size YoY (2018-2033) & (US$ Million)
Figure 24. Europe AI Drug Development Platform Market Share by Type (2018-2033)
Figure 25. Europe AI Drug Development Platform Market Share by Application (2018-2033)
Figure 26. Europe AI Drug Development Platform Market Share by Country (2018-2033)
Figure 27. Germany AI Drug Development Platform Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. France AI Drug Development Platform Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. U.K. AI Drug Development Platform Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Italy AI Drug Development Platform Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Russia AI Drug Development Platform Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Nordic Countries AI Drug Development Platform Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. China AI Drug Development Platform Market Size YoY (2018-2033) & (US$ Million)
Figure 34. China AI Drug Development Platform Market Share by Type (2018-2033)
Figure 35. China AI Drug Development Platform Market Share by Application (2018-2033)
Figure 36. Asia AI Drug Development Platform Market Size YoY (2018-2033) & (US$ Million)
Figure 37. Asia AI Drug Development Platform Market Share by Type (2018-2033)
Figure 38. Asia AI Drug Development Platform Market Share by Application (2018-2033)
Figure 39. Asia AI Drug Development Platform Market Share by Region (2018-2033)
Figure 40. Japan AI Drug Development Platform Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. South Korea AI Drug Development Platform Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. China Taiwan AI Drug Development Platform Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Southeast Asia AI Drug Development Platform Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. India AI Drug Development Platform Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Australia AI Drug Development Platform Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America AI Drug Development Platform Market Size YoY (2018-2033) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America AI Drug Development Platform Market Share by Type (2018-2033)
Figure 48. Middle East, Africa, and Latin America AI Drug Development Platform Market Share by Application (2018-2033)
Figure 49. Middle East, Africa, and Latin America AI Drug Development Platform Market Share by Country (2018-2033)
Figure 50. Brazil AI Drug Development Platform Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 51. Mexico AI Drug Development Platform Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 52. Turkey AI Drug Development Platform Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Saudi Arabia AI Drug Development Platform Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Israel AI Drug Development Platform Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. GCC Countries AI Drug Development Platform Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Insilico Medicine Revenue Growth Rate in AI Drug Development Platform Business (2018-2023)
Figure 57. MindRank Revenue Growth Rate in AI Drug Development Platform Business (2018-2023)
Figure 58. BenevolentAI Revenue Growth Rate in AI Drug Development Platform Business (2018-2023)
Figure 59. Exscientia Revenue Growth Rate in AI Drug Development Platform Business (2018-2023)
Figure 60. Deep Pharma Intelligence Revenue Growth Rate in AI Drug Development Platform Business (2018-2023)
Figure 61. Delta4 Revenue Growth Rate in AI Drug Development Platform Business (2018-2023)
Figure 62. DNDi Revenue Growth Rate in AI Drug Development Platform Business (2018-2023)
Figure 63. Standigm Revenue Growth Rate in AI Drug Development Platform Business (2018-2023)
Figure 64. Genesis Therapeutics Revenue Growth Rate in AI Drug Development Platform Business (2018-2023)
Figure 65. Data2Discovery Revenue Growth Rate in AI Drug Development Platform Business (2018-2023)
Figure 66. Unlearn.AI Revenue Growth Rate in AI Drug Development Platform Business (2018-2023)
Figure 67. Deep Intelligent Pharma Revenue Growth Rate in AI Drug Development Platform Business (2018-2023)
Figure 68. CarbonSilicon AI Technology Revenue Growth Rate in AI Drug Development Platform Business (2018-2023)
Figure 69. XtalPi Revenue Growth Rate in AI Drug Development Platform Business (2018-2023)
Figure 70. Tencent Revenue Growth Rate in AI Drug Development Platform Business (2018-2023)
Figure 71. Fastone Revenue Growth Rate in AI Drug Development Platform Business (2018-2023)
Figure 72. Stonewise Revenue Growth Rate in AI Drug Development Platform Business (2018-2023)
Figure 73. HitGen Revenue Growth Rate in AI Drug Development Platform Business (2018-2023)
Figure 74. Galixir Revenue Growth Rate in AI Drug Development Platform Business (2018-2023)
Figure 75. Matwings Technology Revenue Growth Rate in AI Drug Development Platform Business (2018-2023)
Figure 76. Alibaba Revenue Growth Rate in AI Drug Development Platform Business (2018-2023)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed